Aeris Biosciences has raised $1.5M in pre-seed funding. The company engineers porous biomaterials with micro- and nanoscale hierarchical architectures designed to organize biology - encouraging regenerative cell integration while preventing bacterial colonization.
Its Aer platform spans wound repair, bone regeneration, and localized therapeutic delivery.














